Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Carroll, C. orcid.org/0000-0002-6361-6182, Tappenden, P. orcid.org/0000-0001-6612-2332, Rafia, R. orcid.org/0000-0002-6914-1990 et al. (6 more authors) (2017) Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35 (5). pp. 537-547. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Springer International Publishing Switzerland. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 11 March 2017
  • Published (online): 11 March 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Funding Information:
FunderGrant number
DEPARTMENT OF HEALTHnone
Depositing User: Symplectic Sheffield
Date Deposited: 12 Apr 2017 11:05
Last Modified: 11 Mar 2018 01:38
Published Version: http://doi.org/10.1007/s40273-017-0492-6
Status: Published
Publisher: Adis
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-017-0492-6
Related URLs:

Share / Export

Statistics